Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhalational Versus Total Intravenous Anaesthesia for Hepatocellular Carcinoma Surgery
NCT04601961Unknown
- Sponsor
- The University of Hong Kong
- Start
- Mar 2020
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propofol injection (veterinary) in hepatocellular carcinoma (HCC) (2 arms), sponsored by The University of Hong Kong. Primary endpoint: HIF-1 gene expression at 24 hours. Status: unknown.
02
Drugs
propofol injection (veterinary)
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04601961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601961.